Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionDAVENPORT & Co LLC
Latest Disclosed Ownership41,281 shares
Latest Disclosed Value $ 6,305,741
DAVENPORT & Co LLC ownership in NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 15, 2026 - DAVENPORT & Co LLC filed a 13F-HR form disclosing ownership of 41,281 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $6,305,673 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 37,364 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of 10.48% during the quarter. The current value of the position is $6,157,474 USD.

DAVENPORT & Co LLC has a history of taking positions in derivatives of the underlying security (NVS) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

NVS / Novartis AG - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F NOVARTIS SPONSORED ADR 66987V109 41,281 3,917 10.48 6,306 22.40 0.0343
2026-01-12 2025-12-31 13F NOVARTIS SPONSORED ADR 66987V109 37,364 -4,672 -11.11 5,151 -4.43 0.0274
2025-10-15 2025-09-30 13F NOVARTIS SPONSORED ADR 66987V109 42,036 8,353 24.80 5,391 32.27 0.0287
2025-07-22 2025-06-30 13F NOVARTIS SPONSORED ADR 66987V109 33,683 2,758 8.92 4,076 18.22 0.0222
2025-04-28 2025-03-31 13F NOVARTIS SPONSORED ADR 66987V109 30,925 -1,735 -5.31 3,448 8.46 0.0200
2025-01-24 2024-12-31 13F NOVARTIS SPONSORED ADR 66987V109 32,660 -1,118 -3.31 3,178 -18.20 0.0180
2024-10-24 2024-09-30 13F NOVARTIS SPONSORED ADR 66987V109 33,778 -715 -2.07 3,885 5.80 0.0220
2024-08-06 2024-06-30 13F NOVARTIS SPONSORED ADR 66987V109 34,493 148 0.43 3,672 10.54 0.0222
2024-05-03 2024-03-31 13F NOVARTIS SPONSORED ADR 66987V109 34,345 2,190 6.81 3,322 2.34 0.0204
2024-01-23 2023-12-31 13F NOVARTIS SPONSORED ADR 66987V109 32,155 -973 -2.94 3,247 -3.79 0.0220
2023-10-17 2023-09-30 13F NOVARTIS SPONSORED ADR 66987V109 33,128 -4,080 -10.97 3,374 -10.12 0.0255
2023-07-20 2023-06-30 13F NOVARTIS SPONSORED ADR 66987V109 37,208 -3,407 -8.39 3,755 0.48 0.0276
2023-04-27 2023-03-31 13F NOVARTIS SPONSORED ADR 66987V109 40,615 3,504 9.44 3,737 10.96 0.0293
2023-01-20 2022-12-31 13F NOVARTIS SPONSORED ADR 66987V109 37,111 -616 -1.63 3,367 17.40 0.0275
2022-10-11 2022-09-30 13F NOVARTIS SPONSORED ADR 66987V109 37,727 5,069 15.52 2,868 3.88 0.0249
2022-07-18 2022-06-30 13F NOVARTIS SPONSORED ADR 66987V109 32,658 -795 -2.38 2,761 -5.96 0.0226
2022-05-02 2022-03-31 13F/A-1 NOVARTIS SPONSORED ADR 66987V109 33,453 433 1.31 2,936 1.66 0.0201
2022-05-02 2022-03-31 13F NVS SPONSORED ADR 66987V109 33,453 433 2,936 0.0201
2022-02-10 2021-12-31 13F NVS SPONSORED ADR 66987V109 33,020 -2,345 -6.63 2,888 -0.14 0.0190
2021-10-14 2021-09-30 13F NVS SPONSORED ADR 66987V109 35,365 20,289 134.58 2,892 110.17 0.0204
2021-07-28 2021-06-30 13F/A-2 NOVARTIS SPONSORED ADR 66987V109 15,076 591 4.08 1,376 11.15 0.0106
2021-04-28 2021-03-31 13F NOVARTIS SPONSORED ADR 66987V109 14,485 4,068 39.05 1,238 25.81 0.0116
2021-01-13 2020-12-31 13F NVS ADR 66987V109 10,417 587 5.97 984 15.09 0.0097
2020-10-15 2020-09-30 13F NOVARTIS SPONSORED ADR 66987V109 9,830 -106 -1.07 855 -1.50 0.0096
2020-07-28 2020-06-30 13F NOVARTIS SPONSORED ADR 66987V109 9,936 -200 -1.97 868 3.83 0.0106
2020-05-05 2020-03-31 13F NVS ADR 66987V109 10,136 350 3.58 836 -9.82 0.0120
2020-01-22 2019-12-31 13F NVS ADR 66987V109 9,786 477 5.12 927 9.06 0.0099
2019-10-16 2019-09-30 13F NVS ADR 66987V109 9,309 -5 -0.05 850 0.00 0.0101
2019-07-10 2019-06-30 13F NVS ADR 66987V109 9,314 -482 -4.92 850 -9.77 0.0101
2019-04-17 2019-03-31 13F NVS ADR 66987V109 9,796 -92 -0.93 942 10.95 0.0117
2019-01-28 2018-12-31 13F NVS ADR 66987V109 9,888 869 9.64 849 9.27 0.0117
2018-10-11 2018-09-30 13F NVS ADR 66987V109 9,019 -2,379 -20.87 777 -8.48 0.0090
2018-07-09 2018-06-30 13F NVS ADR 66987V109 11,398 -172 -1.49 1 -100.00 0.0106
2018-04-04 2018-03-31 13F NVS ADR 66987V109 11,570 -605 -4.97 935 -8.51 0.0115
2018-01-17 2017-12-31 13F NVS ADR 66987V109 12,175 5,265 76.19 1,022 72.34 0.0123
2017-10-12 2017-09-30 13F NVS ADR 66987V109 6,910 64 0.93 593 3.85 0.0075
2017-07-18 2017-06-30 13F/A-1 NVS ADR 66987V109 6,846 569 9.06 571 24.95 0.0076
2017-07-10 2017-06-30 13F NVS ADR 66987V109 6,007 438
2017-04-11 2017-03-31 13F NVS ADR 66987V109 6,277 -168 -2.61 457 -19.96 0.0065
2017-01-05 2016-12-31 13F NVS ADR 66987V109 6,445 1,282 24.83 0 -100.00 0.0067
2016-10-19 2016-09-30 13F NVS ADR 66987V109 5,163 -1,704 -24.81 408 -28.09 0.0060
2016-07-12 2016-06-30 13F NVS ADR 66987V109 6,867 2,757 67.08 567 90.57 0.0086
2016-04-25 2016-03-31 13F NVS ADR 66987V109 4,110 -254 -5.82 298 -20.80 0.0047
2016-01-20 2015-12-31 13F NVS ADR 66987V109 4,364 173 4.13 376 -2.60 0.0061
2015-10-23 2015-09-30 13F NVS ADR 66987V109 4,191 -1,464 -25.89 385 -30.76 0.0065
2015-08-12 2015-06-30 13F NOVARTIS ADR 66987V109 5,655 -170 -2.92 556 -3.14 0.0086
2015-04-24 2015-03-31 13F NOVARTIS ADR 66987V109 5,825 5,825 3.01 574 3.24 0.0088
2015-02-04 2014-12-31 13F NOVARTIS ADR 66987V109 0 -7,279 -100.00 0 -100.00
2014-10-10 2014-09-30 13F NOVARTIS ADR 66987V109 7,279 150 2.10 685 6.20 0.0120
2014-07-25 2014-06-30 13F NOVARTIS ADR 66987V109 7,129 -966 -11.93 645 -6.25 0.0110
2014-04-21 2014-03-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,095 -191 -2.31 688 -99.90 0.0125
2014-01-31 2013-12-31 13F NOVARTIS A G SPONSORED ADR 66987V109 8,286 -222 -2.61 666,059 2.05 0.0124
2013-11-05 2013-09-30 13F/A-1 NOVARTIS A G SPONSORED ADR 66987V109 8,508 -1,150 -11.91 652,678 -4.43 0.0135
2013-11-01 2013-09-30 13F NOVARTIS A G SPONSORED ADR 66987V109 9,658 682,944
2013-08-12 2013-06-30 13F NOVARTIS A G SPONSORED ADR 66987V109 9,658 9,658 682,944 0.0151
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-10-14 2021-09-30 13F NOVARTIS SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-07-21 2021-06-30 13F NOVARTIS SPONSORED ADR Put 15,076 1,376 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.